Ben Greenblum focuses on commercial and complex civil litigation. He has tried cases in court and in arbitration. His practice is national in scope, and he has represented both defendants and plaintiffs in high-dollar disputes.
Since 2019, Benchmark Litigation has included Ben in their rankings. He was also selected as a “Rising Star” in the 2014 through 2017 Washington, D.C. editions of Super Lawyers. Ben has experience in a range of substantive areas, including antitrust law, food and drug law, contract disputes, intellectual property, and class actions. In his antitrust practice, Ben not only represents clients in litigation, but also counsels them on competition matters.
In 2017, Ben co-authored a chapter titled “The Philosophy of Food and Drug Law” in the Food & Drug Law Institute’s A Practical Guide to FDA’s Food & Drug Law and Regulation, Sixth Edition.
A native of Washington, D.C., Ben graduated summa cum laude with both a B.S. from the Wharton School and a B.A. from the College of Arts & Sciences at the University of Pennsylvania in 2001. He earned a J.D. from Columbia Law School in 2006, where he was a James Kent Scholar and an editor of the Columbia Law Review. He joined the firm in 2007 after clerking for the Honorable Dennis Jacobs, Chief Judge, United States Court of Appeals for the Second Circuit.
- Represents several pharmaceutical companies in so-called “reverse payment” antitrust litigation
- Represented pharmaceutical compny in first-of-its-kind multi-billion dollar antitrust trial
- Represents food manufacturer in several cases involving alleged unfair trade practices.
- Represents pharmaceutical firms in contract disputes regarding licensing and joint venture agreements.